Holen Sie sich die Stockscreener-App
2.67
12.18%
0.29
Handel nachbörslich:
2.57
-0.10
-3.75%
Schlusskurs vom Vortag:
$2.38
Offen:
$2.46
24-Stunden-Volumen:
455.43K
Relative Volume:
0.48
Marktkapitalisierung:
$1.34M
Einnahmen:
$29.78M
Nettoeinkommen (Verlust:
$-39.94M
KGV:
-0.0431
EPS:
-61.9139
Netto-Cashflow:
$-16.12M
1W Leistung:
+7.23%
1M Leistung:
-56.80%
6M Leistung:
-13.59%
1J Leistung:
-97.15%
1-Tages-Spanne:
$2.40
$2.67
1-Wochen-Bereich:
$2.26
$2.67
52-Wochen-Spanne:
$0.432
$93.82
22nd Century Group, Inc. Stock (XXII) Company Profile
Firmenname
22nd Century Group, Inc.
Sektor
Branche
Telefon
716-270-1523
Adresse
8560 Main Street, Williamsville, NY
Vergleichen Sie XXII mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
2.67 | 790.69K | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2022-06-15 | Eingeleitet | Craig Hallum | Buy |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-23 | Eingeleitet | Cowen | Outperform |
| 2017-10-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-08-11 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
22nd Century Group, Inc. Aktie (XXII) Neueste Nachrichten
22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less - ADVFN Brasil
22nd Century Group Inc expected to post a loss of $6.21 a shareEarnings Preview - TradingView
22nd Century to Release Financials Aug. 14 - Tobacco Reporter
22nd Century Group to Announce Second Quarter 2025 Results on Au - GuruFocus
22nd Century Group to Announce Second Quarter 2025 Results on August 14, 2025 - The Manila Times
Anti-Smoking Pioneer 22nd Century Group Earnings: What to Expect From Q2 2025 Results - Stock Titan
22nd Century Group Announces Reduced-Nicotine Cigarette Launch - Tobacco Reporter
22nd Century Announces First Shipments of Pinnacle VLN® Products - GuruFocus
First-Ever FDA-Approved 95% Reduced Nicotine Cigarettes Hit 1000 Major US Stores - Stock Titan
Is 22nd Century Group Inc. a good long term investmentMaximize portfolio value with expert tips - Jammu Links News
Is 22nd Century Group Inc. a growth stock or a value stockUnmatched profit potential - Jammu Links News
What institutional investors are buying 22nd Century Group Inc. stockBuild a portfolio that outperforms the market - Jammu Links News
What catalysts could drive 22nd Century Group Inc. stock higher in 2025Invest smarter with actionable stock recommendations - Jammu Links News
Why is 22nd Century Group Inc. stock attracting strong analyst attentionAccelerated wealth building - Jammu Links News
How volatile is 22nd Century Group Inc. stock compared to the marketRealize consistent double-digit growth - Jammu Links News
When is 22nd Century Group Inc. stock expected to show significant growthInvest smarter with comprehensive market analysis - Jammu Links News
Should I hold or sell 22nd Century Group Inc. stock in 2025Discover breakthrough trading strategies - Jammu Links News
What are 22nd Century Group Inc. company’s key revenue driversRealize consistent double-digit growth - Jammu Links News
How strong is 22nd Century Group Inc. company’s balance sheetBuild a diversified portfolio for maximum returns - Jammu Links News
How many analysts rate 22nd Century Group Inc. as a “Buy”Tremendous growth potential - Jammu Links News
What is the risk reward ratio of investing in 22nd Century Group Inc. stockIdentify undervalued stocks poised to rally - Jammu Links News
How does 22nd Century Group Inc. compare to its industry peersCapitalize on market shifts with expert advice - Jammu Links News
What are the latest earnings results for 22nd Century Group Inc.Invest in stocks with strong fundamentals - Jammu Links News
What is 22nd Century Group Inc. company’s growth strategyCapitalize on fast-moving stock opportunities - Jammu Links News
What are analysts’ price targets for 22nd Century Group Inc. in the next 12 monthsChart Pattern Trend Scanner With Low Risk - jammulinksnews.com
Will 22nd Century Group Inc. stock recover after recent dropROI Boosting Trade Opportunity Calendar Published - metal.it
Why 22nd Century Group Inc. stock attracts strong analyst attentionProven Entry Plan With Low Risk Shared - metal.it
22nd Century Applauds the American Academy of Family Physicians Comments and Support of the FDA’s Proposed Reduced Nicotine Mandate to Reduce Smoking, Transform Public Health, Save Lives and Reduce Health Costs - The Manila Times
22nd Century Group comments on FDA’s proposed nicotine standard By Investing.com - Investing.com Australia
22nd Century Group, Inc. Highlights FDA Authorization of VLN® Products as Compliant Reduced Nicotine Cigarettes - Quiver Quantitative
22nd Century Group comments on FDA’s proposed nicotine standard - Investing.com India
Medical Group Backs FDA's Historic Nicotine Ban: 22nd Century Holds Exclusive Compliant Products - Stock Titan
What makes 22nd Century Group Inc. stock attractive to long term investorsHigh Yield Stock Screening Results Explained - metal.it
XXII Stock Surge: Time for Action? - StocksToTrade
22nd Century Group Inc. Breaks Losing Streak — Is the Trend ReversingConfirmed Setup With Expert Accuracy Supported - metal.it
22nd Century Group: Resurgence and Future Prospects - StocksToTrade
22nd Century Group’s Bold Leap: A Market Game-Changer? - timothysykes.com
Finanzdaten der 22nd Century Group, Inc.-Aktie (XXII)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):